Jun 2020| Report Format: Electronic (PDF)
Recent Developments
· In 2020, GE Healthcare has launched the Edison Developer Program to accelerate the adoption and impact of intelligent applications and developer services across health systems. The program is based on Edison, GE Healthcare’s secure intelligence platform, and helps healthcare providers gain easier access to market-ready algorithms and applications by directly integrating these technologies into existing workflows. It has a crucial role in boosting the technological advancements in brain tumor therapy and diagnosis.
· In December 2019, GE Healthcare today launched more than 30 new, imaging intelligent applications and smart devices designed to drive efficiency in radiology departments, aiming to double productivity and cost savings for systems by 2025. For healthcare executives, the new offerings help systems to save costs, improve technology utilization, and increase patient volumes. Clinicians also will benefit from the new technologies through intuitive workflows, improved diagnostic confidence and less rework, allowing them to spend more time with patients. This will be particularly beneficial for patients affected by brain tumors and are going through its treatment.
· In 2017, GE Healthcare builds out AI, radiology partnerships with Intel, Nvidia. The new CT system is two times faster in imaging processing than its predecessor, due to its use of Nvidia’s AI computing platform. The technology, called Revolution Frontier is FDA-cleared and expected to deliver better clinical outcomes in liver lesion detection and kidney lesion characterization because of its speed — potentially reducing the need for unnecessary follow-ups, benefitting patients with compromised renal function and reducing non-interpretable scans with Gemstone Spectral Imaging Metal Artefact Reduction.
GE Healthcare also announced on Sunday a separate partnership with Intel, which is aimed at boosting patient care and reducing costs for hospitals and health systems using digital imaging solutions, deployed via edge and cloud.
· In February 2019, Hitachi Healthcare presented next levels of diagnostic imaging solutions: the new CT scan, the SCENARIA View, the new high field MRI system, the ECHELON Smart Plus, and SynergyDrive suite at European Society of Radiology (ECR), Vienna, Austria. The SCENARIA View enhances patient comfort with an open design allowing to both accommodating the largest of patients and precise clinical targeting to feature high dose reduction. ECHELON Smart Plus is a next level 1.5T conventional superconductive MRI system, featuring state-of-the-art technology and enhanced productivity with uncompromised diagnostic value. SynergyDrive represents comprehensive hardware and software that is designed to streamline operations for examinations for MRI, and CT modalities.
· In February 2020, Hitachi Healthcare Americas has announced that it will create a new dedicated research and development facility within its North American headquarters facility in Twinsburg, Ohio, USA. Set to open this year, the Hitachi Healthcare Innovation Center of Excellence will leverage advancements in artificial intelligence and machine learning to bring about a new generation of imaging technology. This center will be of great help for the brain tumor patients and will play a crucial role in their diagnosis.
· In April 2019, Royal Philips announced IntelliSpace Radiation Oncology, an intelligent patient management solution to manage complexity, improve efficiency, and enable operational excellence in radiotherapy departments. It provides a harmonized way of working, integrating applications and automating workflow to help reduce the amount of time it takes from receiving a patient referral to the start of their treatment.
· In March 2020, Philips Receives Global AI for Enhanced Radiology Interpretation Company of The Year Award from Frost & Sullivan, based on its recent analysis of the global market for Artificial Intelligence (AI) for enhanced radiology interpretation market. This award tells a lot about the credibility and quality of the products from company. Also, the award recognizes a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and market penetration.
· In December 2019, it was announced that FUJIFILM Corporation (Tokyo, Japan) has entered into an agreement with Hitachi, Ltd. (Tokyo, Japan) to acquire its Diagnostic Imaging-related business to further expand its Healthcare business. By applying its proprietary image processing and artificial intelligence (AI) technologies to Hitachi’s extensive product lineup, Fujifilm aims to further expand its Medical Systems business and create new values to contribute to improve the quality of medical care.
